Loading clinical trials...
Loading clinical trials...
Direct oral anticoagulants (DOAC) are anticoagulant molecules that act either directly on factor Xa (Apixaban, Rivaroxaban) or on factor IIa (Dabigatran). AODs interfere with most coagulation tests, ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Hospital, Strasbourg, France
NCT07372170 · Antiphospholipid Syndrome (APS), Venous Thrombosis (Disorder), and more
NCT07108023 · Extrahepatic Portal Vein Obstruction (EHPVO), Thrombophilia, and more
NCT00883272 · Menopause, Thrombophilia
NCT01905748 · Migraine, Thrombophilia
NCT02407730 · Birth Rate, Embryo Implantation, and more
Laboratoire d'Hématologie - CHU de Strasbourg - France
Strasbourg
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions